Preetesh Patel, MD
Orthopaedic Surgery · Weston, FLNPI 1578661286
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $217,125 of the $256,008 with a category attached, or 84.8%. Stryker accounts for 62.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $120,479 and has fallen 96.5% since, to $4,176 in 2025. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 410 payments — averaging $624.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$161K
- Zimmer Biomet$92K
- Carbofix Orthopedics Inc$3K
- Johnson & Johnson$408
- Medtronic$182
- Onkos Surgical, Inc.$88
- plus $232 from 5 others
Across 3 payments — averaging $456.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Orthosensor Inc.$1K
What the payments were for
- Royalty or licence$2,3281%
- Consulting fees$217,12585%
- Travel & lodging$20,9028%
- Food & beverage$13,1535%
- Education$2,5001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 238 | $160,876 |
| Zimmer Biomet | 157 | $91,721 |
| Carbofix Orthopedics Inc | 1 | $2,500 |
| Johnson & Johnson | 4 | $408 |
| Medtronic(2 entities) | 3 | $182 |
| Onkos Surgical, Inc. | 1 | $88 |
| Biocomposites Inc | 1 | $70 |
| Kyocera Medical Technologies, Inc. | 1 | $60 |
| KCI USA, Inc. | 2 | $52 |
| Smith+Nephew | 1 | $25 |
| Abbott | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$103,857
- ACCOLADE$50,786
- PD-Hip-New Product$37,322
- PD-Knee-New Product$13,965
- TRIDENT$10,835
- RESTORATION$10,639
- TRITANIUM$10,500
- CMF & Thoracic-None$5,000
- TRIATHLON$4,658
- CarboFix Orthopedics Nail & Plate$2,500
- ROSA$2,328
- ROSA-Knee$1,308
- STRATAFIX$254
- Persona$227
- NEW PRODUCT DEVELOPMENT$121
- Rosa-Hip$119
- All Osseotite Implants$119
- Arcos$119
- NCB Instruments/Plates/Screws$116
- MONOCRYL$115
How this compares
$256,008 in reported general payments places this provider in the 90th percentile of 1,263 orthopaedic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 107 | $785 |
| Meloxicam | 22 | $41 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Weston
- Alfred DesimoneWeston$867K
- Andrew CooperClearwater$102M
- Richard HynesMelbourne$34.8M
- Mark FrankleTemple Terrace$31M
- Roy SandersTemple Terrace$19.6M
- George HaidukewychOrlando$10M
- Robert SantrockFernandina Beach$7.3M
- Martin RocheFt. Lauderdale$7.1M
- Steven LyonsTampa$6.7M
- Thomas BernasekTemple Terrace$6.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.